🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The main objective of the trial is to demonstrate the efficacy of dupilumab...
Status
Completed
Location
Regeneron Research Site
Start Date
2017-11-17
Trial ID
NCT03345914
This 4-week study will evaluate the safety and efficacy of crisaborole oint...
Status
Terminated
Location
Dermatology Trial Associates
Start Date
2018-04-27
Trial ID
NCT03539601
The primary objective of the study was to demonstrate the efficacy of Dupil...
Status
Completed
Location
Multiple Locations
Start Date
2014-09
Trial ID
NCT02260986
Treatments Being Tested
The primary purpose of this study is to investigate the safety of pimecroli...
Status
Completed
Location
Phoenix Children's Hospital
Start Date
2004-04
Trial ID
NCT00120523
Treatments Being Tested
This is a two-part, multicenter, randomized, double-blind study to evaluate...
Status
Terminated
Location
Cara Therapeutics Study Site
Start Date
2022-08-16
Trial ID
NCT05387707
Treatments Being Tested
This randomized, double-blind, placebo-controlled study will evaluate the s...
Status
Completed
Location
Dermatology Research Associate
Start Date
2015-05
Trial ID
NCT02340234
Treatments Being Tested
One of the most frequent skin conditions is atopic dermatitis (AD), charact...
Status
Completed
Location
Tanta Unuversity
Start Date
2022-10-28
Trial ID
NCT05607901
Treatments Being Tested
The main objective of the study consists in characterizing the immune cells...
Status
Unknown
Location
Service d'Allergologie et Immunologie Clinique - Hôpital Lyon Sud
Start Date
2020-03-09
Trial ID
NCT03983460
Treatments Being Tested
Atopic dermatitis, also called eczema, is characterized by redness, papulat...
Status
Completed
Location
Pediatric Care Medical Group, Inc.
Start Date
2005-05
Trial ID
NCT00121381
This study is to assess infant outcomes of women with AD who were exposed t...
Status
Recruiting
Location
Syneos Health (remote site)
Start Date
2023-03-27
Trial ID
NCT06627335
Treatments Being Tested